Comparing Augmedix (NASDAQ:AUGX) & Quhuo (NASDAQ:QH)

Quhuo (NASDAQ:QH) and Augmedix (NASDAQ:AUGX) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.

Earnings & Valuation

This table compares Quhuo and Augmedix”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quhuo	$521.47 million	0.01	$470,000.00	N/A	N/A
Augmedix	$51.58 million	2.21	-$19.17 million	($0.43)	-5.42

Quhuo has higher revenue and earnings than Augmedix.

Insider & Institutional Ownership

0.2% of Quhuo shares are owned by institutional investors. Comparatively, 87.1% of Augmedix shares are owned by institutional investors. 33.1% of Quhuo shares are owned by company insiders. Comparatively, 11.0% of Augmedix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for Quhuo and Augmedix, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quhuo	0	0	0	0	N/A
Augmedix	0	4	0	0	2.00

Augmedix has a consensus price target of $3.09, suggesting a potential upside of 32.51%. Given Augmedix’s higher probable upside, analysts plainly believe Augmedix is more favorable than Quhuo.

Profitability

This table compares Quhuo and Augmedix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Quhuo	N/A	N/A	N/A
Augmedix	-46.23%	-182.36%	-43.21%

Volatility and Risk

Quhuo has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Comparatively, Augmedix has a beta of -0.22, indicating that its stock price is 122% less volatile than the S&P 500.

Summary

Quhuo beats Augmedix on 7 of the 10 factors compared between the two stocks.

About Quhuo

Quhuo Limited, through its subsidiaries, operates a workforce operational solution platform in the People's Republic of China. It provides tech-enabled and end-to-end operational solutions to on-demand consumer service businesses in industries, including food and grocery delivery, bike-sharing, ride-hailing, and housekeeping. The company also offers ride hailing solutions for ride-hailing companies; housekeeping solutions and other services for short-term rental properties and hotel cleaning services; and shared-bike maintenance solutions to address the demand for maintenance and distribution services from bike-sharing companies, as well as freight services. In addition, it engages in the development of computer software and applications; and investment holding activities. The company was founded in 2012 and is based in Beijing, the People's Republic of China.

About Augmedix

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.